Morten Herholdt's Stock Ratings

HSBC Analyst

Morten Herholdt is an analyst at HSBC. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

-9.01%

Smart Score

35.5%

Overall Average Return Percentile

19th

Number of Ratings

17
Buy NowGet Alert
10/30/2024LHBuy Now
Labcorp Holdings
$258.11UpgradeHold → BuyGet Alert
05/08/2024ZTSBuy Now
Zoetis
$123.2382.59%$230 → $225MaintainsBuyGet Alert
05/03/2024BIIBBuy Now
Biogen
$171.5099.42%$339 → $342MaintainsBuyGet Alert
04/24/2024GILDBuy Now
Gilead Sciences
$118.78-41.91% → $69UpgradeReduce → HoldGet Alert
04/18/2024JNJBuy Now
Johnson & Johnson
$208.85-18.6%$169 → $170UpgradeHold → BuyGet Alert
03/05/2024BLUEBuy Now
bluebird bio
$2.31 → $1.02MaintainsReduceGet Alert
09/06/2023LHBuy Now
Laboratory Corp
$258.11-18.64% → $210Initiates → HoldGet Alert
09/06/2023ZTSBuy Now
Zoetis
$123.2386.64% → $230Initiates → BuyGet Alert
09/06/2023UNHBuy Now
UnitedHealth Group
$334.2861.54% → $540Initiates → HoldGet Alert
09/06/2023LIVNBuy Now
LivaNova
$63.08-17.56% → $52Initiates → HoldGet Alert
09/06/2023JNJBuy Now
Johnson & Johnson
$208.85-16.21% → $175Initiates → HoldGet Alert
09/06/2023IQVBuy Now
IQVIA Hldgs
$221.6817.29% → $260Initiates → BuyGet Alert
09/06/2023GILDBuy Now
Gilead Sciences
$118.78-40.23% → $71Initiates → ReduceGet Alert
09/06/2023BLUEBuy Now
bluebird bio
→ $4.21Initiates → BuyGet Alert
09/06/2023BIIBBuy Now
Biogen
$171.50109.91% → $360Initiates → BuyGet Alert
09/06/2023AMGNBuy Now
Amgen
$326.74-2.06% → $320Initiates → BuyGet Alert
09/06/2023ATNMBuy Now
Actinium Pharma
→ $11.6Initiates → BuyGet Alert